Optimization of a pre-metabolization procedure using rat liver S9 and cell-extracted S9 in the Ames fluctuation test

被引:0
|
作者
Shao, Ying [1 ,2 ]
Schiwy, Andreas [3 ,4 ,5 ]
Glauch, Lisa [1 ]
Henneberger, Luise [1 ]
König, Maria [1 ]
Mühlenbrink, Marie [1 ]
Xiao, Hongxia [3 ,4 ]
Thalmann, Beat [4 ]
Schlichting, Rita [1 ]
Hollert, Henner [3 ,4 ,5 ]
Escher, Beate I. [1 ,4 ,6 ]
机构
[1] UFZ – Helmholtz Centre for Environmental Research, Department of Cell Toxicology, Permoser Str. 15, Leipzig,04318, Germany
[2] Key Laboratory of the Three Gorges Reservoir Eco-environment, Ministry of Education, Chongqing University, Shazheng street 174, Shapingba, Chongqing,400044, China
[3] Department of Ecosystem Analysis, Institute for Environmental Research, RWTH Aachen University, Worringerweg 1, Aachen,52074, Germany
[4] EWOMIS GmbH, Schießstraße 26c, Bruchköbel,63486, Germany
[5] Department of Evolutionary Ecology and Ecotoxicology, Goethe University, Max-von-Laue-Str. 13, Frankfurt/Main,60438, Germany
[6] Eberhard Karls University of Tübingen, Environmental Toxicology, Centre for Applied Geosciences, Tubingen,72074, Germany
关键词
Detoxification;
D O I
暂无
中图分类号
学科分类号
摘要
Many environmental pollutants pose a toxicological hazard only after metabolic activation. In vitro bioassays using cell lines or bacteria have often no or reduced metabolic activity, which impedes their use in the risk assessment. To improve the predictive capability of in vitro assays, external metabolization systems like the liver S9 fraction are frequently combined with in vitro toxicity assays. While it is typical for S9 fractions that samples and testing systems are combined in the same exposure system, we propose to separate the metabolism step and toxicity measurement. This allows for a modular combination of metabolic activation by enzymes isolated from rat liver (S9) or a biotechnological alternative (ewoS9R) with in vitro bioassays that lack metabolic capacity. Benzo(a)pyrene and 2-aminoanthracene were used as model compounds to optimize the conditions for the S9 metabolic degradation/activation step. The Ames assay with Salmonella typhimurium strains TA98 and TA100 was applied to validate the set-up of decoupling the S9 activation/metabolism from the bioassay system. S9 protein concentration of 0.25 mgprotein/mL, a supplement of 0.13 mM NADPH and a pre-incubation time of 100 min are recommended for activation of samples prior to dosing them to in vitro bioassays using the regular dosing protocols of the respective bioassay. EwoS9R performed equally well as Moltox S9, which is a step forward in developing true animal-free in vitro bioassays. After pre-incubation with S9 fraction, chemicals induced bacteria revertants in both the TA98 and the TA100 assay as efficiently as the standard Ames assay. The pre-incubation of chemicals with S9 fraction could serve for a wide range of cellular in vitro assays to efficiently combine activation and toxicity measurement, which may greatly facilitate the application of these assays for chemical hazard assessment and monitoring of environmental samples. © 2020 Elsevier B.V.
引用
收藏
相关论文
共 50 条
  • [41] Frameshift mutagenicity and DNA intercalation of 9-amino-2-hydroxyacridine, a rat liver S9 metabolite of 9-aminoacridine
    Tomosaka, H
    Anzai, K
    Hasegawa, E
    Horigome, T
    Omata, S
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1996, 60 (04) : 714 - 716
  • [42] Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on a MVLN cell using a luciferase reporter gene assay
    Jae Soon Kang
    Jin-Soo Choi
    Woo-Keun Kim
    Yong-Ju Lee
    June-Woo Park
    Reproductive Biology and Endocrinology, 12
  • [43] Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on a MVLN cell using a luciferase reporter gene assay
    Kang, Jae Soon
    Choi, Jin-Soo
    Kim, Woo-Keun
    Lee, Yong-Ju
    Park, June-Woo
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2014, 12
  • [44] Optimization and application of the head space liver S9 equilibration technique for metabolic studies of organic solvents
    Mortensen, B
    Nilsen, OG
    PHARMACOLOGY & TOXICOLOGY, 1998, 82 (03): : 142 - 146
  • [45] METABOLIC BIOACTIVATION OF PIPERAZINE IN BNAPHTHOFLAVONE AND PHENOBARBITAL OR AROCROL 1254 INDUCED RAT LIVER S9 FRACTIONS
    Gunduz, Mithat
    Kamel, Amin
    Klimko, Peter
    Colizza, Kevin
    Harriman, Shawn
    DRUG METABOLISM REVIEWS, 2014, 45 : 80 - 80
  • [46] INHIBITION OF RETINOID TOXICITY BY RAT-LIVER S9 FRACTION IN CULTURED MAMMALIAN-CELLS
    QIN, S
    SIRIANNI, SR
    HUANG, CC
    CANCER LETTERS, 1983, 21 (02) : 201 - 210
  • [47] INCREASED MUTAGENICITY OF CARCINOGENIC NITROSO-COMPOUNDS USING HAMSTER LIVER S9 PREPARATIONS
    RAINERI, R
    POILEY, JA
    ANDREWS, AW
    ENVIRONMENTAL MUTAGENESIS, 1980, 2 (02): : 305 - 305
  • [48] Monitoring paraquat and redox cycling processes in rat liver S9 mixes using screene printed electrochemical sensors
    Pariagh, S
    Hart, JP
    Hurst, R
    O'Donovan, MR
    TOXICOLOGY, 2004, 202 (1-2) : 69 - 69
  • [49] ACTIVATION OF PRO-MUTAGENS IN COMPLEX-MIXTURES BY RAT-LIVER S9 SYSTEMS
    COURTOIS, YA
    PESLE, ML
    FESTY, B
    MUTATION RESEARCH, 1992, 276 (1-2): : 133 - 137
  • [50] Comparative study in the Ames test of benzo[a]pyrene and 2-aminoanthracene metabolic activation using rat hepatic S9 and hepatocytes following in vivo or in vitro induction
    Jemnitz, K
    Veres, Z
    Torok, G
    Toth, E
    Vereczkey, L
    MUTAGENESIS, 2004, 19 (03) : 245 - 250